Similar articles

• Cerebrotendinous xanthomatosis: evidence of lipomatous hypertrophy of the atrial septum.

  Dotti MT, Mondillo S, Plewnia K, Agricola E, Federico A. Dotti MT, et al. J Neurol. 1998 Nov;245(11):723-6. doi: 10.1007/s004150050274. J Neurol. 1998. PMID: 9808240
• Cerebrotendinous xanthomatosis: a treatable cause of metabolic ataxia.

  Mukherjee AA, Chawla BP, Rathi SS, Puthran RS. Mukherjee AA, et al. J Assoc Physicians India. 2007 Sep;55:655-7. J Assoc Physicians India. 2007. PMID: 18051740
• Pulmonary lymphangioleiomyomatosis and cerebrotendinous xanthomatosis: is there a link?

  Dormans TP, Verrips A, Bulten J, Cox N. Dormans TP, et al. Chest. 1997 Jul;112(1):273-4. doi: 10.1378/chest.112.1.273. Chest. 1997. PMID: 9228390
• Blepharospasm as a new feature of cerebrotendinous xanthomatosis.

  Lagarde J, Sedel F, Degos B. Lagarde J, et al. Parkinsonism Relat Disord. 2013 Aug;19(8):764-5. doi: 10.1016/j.parkreldis.2013.04.003. Epub 2013 Apr 25. Parkinsonism Relat Disord. 2013. PMID: 23623195 No abstract available.
• Device closure of fenestrated atrial septal aneurysm: difficulties and complications with implantation of two devices.

  Tchana B, Hagler DJ, Carano N, Agnetti A, Squarcia U. Tchana B, et al. J Invasive Cardiol. 2004 Sep;16(9):532-4. J Invasive Cardiol. 2004. PMID: 15353814 Review. No abstract available.